Bipolar Disorder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2940 | Report Format : | Status : Upcoming |

Abstract

Global Bipolar Disorder Market: Overview

Bipolar disorder is usually recognized as manic depression, it is a kind of mental illness which is mainly categorized by mood swings. Mood episodes are basically of two types: depressive and manic episodes. The changes or transformation in the mental condition can bring out sudden low or high moods in an individual. An individual who is suffering from bipolar disorder might be joyful, happy, and energized at a meticulous moment and may also be hopeless, sad, and lethargic at the next moment.

Global Bipolar Disorder Market: Growth Factors

The global bipolar disorder market is likely to be driven by the augment in the occurrence of bipolar disorder, several government initiatives to boost public knowledge about the effects of bipolar disorders, need to decrease the disease burden of bipolar disorder, and high demand and requirement for anti-depressants. On the other hand, the dearth of exact diagnostic methods for the identification of the syndrome/disorder as well as the side effects related to bipolar disorder is projected to hinder the market development. On the contrary, a development which is associated with combination therapies of medicines will offer lucrative prospects for the market development in the coming future.

Global Bipolar Disorder Market: Segmentation

The global bipolar disorder market is categorized in terms of types of bipolar disorder, mechanism of action, drug class, and region. In terms of bipolar disorder types, the market is fragmented into bipolar I disorder, it is a mixed or manic episode; bipolar II disorder, it is depression and hypomania; and cyclothymia, it is mild depression and hypomania. In terms of drug class, the global bipolar disorder market is divided into anticonvulsants, mood stabilizers, antidepressants, antipsychotics, and anti-anxiety drugs. Based on the mechanism of action, the global market is classified into serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, beta blockers, benzodiazepines, and others.

Global Bipolar Disorder Market: Regional Analysis

In terms of region, the global bipolar market is classified into the Middle East & Africa, Europe, North America, Latin America, and the Asia Pacific. North America is projected to dominate and lead the global bipolar disorder market owing to augmented knowledge and larger accessibility of treatment alternatives. The U.S. is likely to have a significant market share based on revenue, which is expected to be followed by Canada. Europe is likely to be the second dominating region, which is projected to contribute to the development of the global bipolar disorder market based on revenue, along with Germany and the U.K., having a significant market share of the global market. The Asia Pacific is expected to be the extremely prospective market with developing countries such as China and India. Augment in knowledge about the syndromes in the emerging countries is anticipated to fuel and contribute to the expansion of the global market owing to growing economy and increasing knowledge about the mental sickness.

Global Bipolar Disorder Market: Competitive Players

Some of the most important market players in the global bipolar disorder market are AstraZeneca., Pfizer Inc., Glaxo SmithKline (GSK), Eli Lilly, Janssen Pharmaceuticals, Novartis AG, Allergan Plc., Otsuka Holdings Co. Ltd., and AbbVie Inc., among others.

Global Bipolar Disorder Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.